ETF Financing Ranking | GF CSI HK Innovative Drugs Industry ETF(QDII) (513120) had a net financing buy-in of CNY 178.74 million, ranked first in the entire market-20260610

NewTimeSpace (newtimespace.com) News, Jun 10, 2026, GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.SH) increased by 1.12%, had a turnover of CNY 5.35 billion. Obtained financing buy-in of CNY 716.25 million, and financing repayment of CNY 537.51 million, with a net financing buy-in of CNY 178.74 million, ranked first in the entire market. (Data source: Wind)

Over a longer period, had leveraged funds with accelerated inflow over the last 4 days, with a total inflow of CNY 319.28 million, ranked top in the entire market. (Data source: Wind)

GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.SH), off-exchange connection (A type: 019670; C type: 019671).

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.